1631 – Home sleep apnoea test utilizing peripheral arterial tone

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Not supported

Application details

Reason for application

Amendment to existing MBS item.

Service or technology in this application

The proposed medical service is a Home Sleep Apnoea Test (HSAT). The HSAT measures seven channels: peripheral arterial tone (PAT) signal, oximetry, actigraphy, heart rate, body position, snoring, and chest movement. By using these seven channels, the PAT HSAT can differentiate between sleep periods and awake time periods, which allows the analysis of 'true sleep time', and can report sleep stages (light, deep, and rapid eye movement sleep), apnea hypopnea index, oxygen desaturation index, and other major indices necessary for the diagnosis of obstructive sleep apnoea.

Type: Investigative

Medical condition this application addresses

Sleep apnoea is a common sleep-related breathing disorder. The most prevalent type of sleep apnoea is obstructive aleep apnoea (OSA), which is characterized by a narrowing of the upper airway that impairs normal ventilation during sleep , resulting in repeated reversible blood oxygen desaturation and fragmented sleep. OSA has been associated with a range of pathophysiological changes that impair cardiovascular function, including increased blood inflammatory markers and repeated rises in blood pressure . OSA is strongly linked to a variety of health problems such as coronary heart disease, stroke, atrial fibrillation, diabetes, hypertension and greater mortality risk.

Meetings to consider this application

  • PASC meeting: 13 August 2020
  • ESC meeting: 10 to 11 June 2021
  • MSAC meeting: 29 to 30 July 2021